Welcome to our dedicated page for Im Cannabis SEC filings (Ticker: IMCC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IM Cannabis Corp. (IMCC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer listed on the Nasdaq Capital Market. IM Cannabis files reports with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F and multiple current reports on Form 6-K.
Through these filings, investors can review financial statements and MD&A for IM Cannabis’ operations in Israel and Germany. Form 6-K submissions include unaudited interim condensed consolidated financial statements and management’s discussion and analysis for periods such as the three and nine months ended September 30, 2025. These documents discuss revenue, gross margin, operating expenses, non-IFRS measures like Adjusted EBITDA, and notes regarding the company’s ability to continue as a going concern.
Filings also cover governance and leadership changes, such as the appointment of a new Chief Financial Officer, the planned departure of the previous CFO, and board and committee changes. Related Form 6-K reports often attach the underlying press releases and describe whether any related party transactions are present or need disclosure under Form 20-F requirements.
Another important category is capital markets and securities information. IM Cannabis has filed Form 6-K reports detailing amendments to common share purchase warrants, including changes to exercise prices and expiration dates, as well as the filing of a resale registration statement on Form F-3. Early warning and related party disclosures are also summarized in these materials.
Stock Titan’s platform surfaces these IMCC filings as they are furnished to EDGAR and applies AI-powered summaries to help explain the contents of lengthy documents, such as MD&A sections and financial statement notes. Users can quickly locate quarterly information, board and management updates, and transaction-related disclosures, while also drilling down into the full text of Form 6-K and Form 20-F filings when deeper analysis is required.
Cannabis Corp. reports multiple board changes and a new strategic direction. Two directors, Shmulik Arbel and Brian Schinderle, resigned from the board and its audit and compensation committees, as applicable, effective September 15, 2025. The board appointed Asaf Yitzhaik, a veteran retail and real estate businessman and director at several listed companies, and Eli Zamir, a finance and capital markets executive, to the board and audit committee, with Zamir also joining the compensation committee.
The company also named existing director Oz Adler as Chairman of the Board, replacing Oren Shuster, who continues as CEO and director. Alongside these governance changes, the company decided, as part of its ongoing strategic review, to explore introducing additional business activities to support long-term growth and shareholder value. This report is incorporated by reference into Cannabis Corp.’s Form F-3 registration statements.
IM Cannabis Corp. furnished a Current Report on Form 6-K that includes a press release dated
IM Cannabis Corp. amended certain common share purchase warrants issued in its 2024 private placement by reducing the exercise price from C$4.32 to C$3.43 and extending the expiration date from November 12, 2026 to July 31, 2030. The warrants were originally exercisable upon issuance and, except for the exercise price and expiration, all other terms remain unchanged.
The amendments increase the timeframe and the lower threshold at which warrant holders may convert into common shares, which could raise the likelihood of exercise and therefore the potential for dilution if exercised. The Form of Warrant, the Form of Amendment and a press release are included as exhibits and the report is incorporated by reference into the company’s Form F-3 registration statements.
IM Cannabis Corp. submitted a Form 6-K reporting for the month of August 2025 and furnished several attachments dated August 12, 2025. The report includes a news release, interim consolidated financial statements for the three- and six-month periods ended June 30, 2025, a management's discussion and analysis (MD&A) for those periods, and CEO and CFO certifications of the interim filings. The form is signed by Oren Shuster as Chief Executive Officer and Director. The company indicates it files annual reports on Form 20-F.
IM Cannabis Corp. (IMCC) filed a Form 6-K announcing a new debt financing and a board change. On 6 July 2025 the company signed a Loan Agreement with L.I.A. Pure Capital Ltd. for up to US$2 million. The company has already received the first tranche of US$1 million; a second tranche of US$1 million may be drawn within 60 days, contingent on unspecified conditions.
The agreement grants the lender a right to recommend one director to the board. Pursuant to this right, Mr. Oz Adler, CPA, was appointed to IMCC’s board effective 6 July 2025. Adler is currently CEO and CFO of SciSparc Ltd. and sits on the boards of several Nasdaq-listed companies, bringing managerial, accounting and capital-markets experience.
The Loan Agreement (Exhibit 10.1) and a related press release dated 9 July 2025 (Exhibit 99.1) are furnished with the filing. Except for two specified paragraphs of the press release, the entire 6-K is incorporated by reference into IMCC’s Form F-3 registration statement (File No. 333-288346).
Key takeaways for investors:
- Immediate liquidity boost of US$1 million with potential for an additional US$1 million.
- New debt introduces repayment obligations not yet disclosed in the filing.
- Lender’s nomination right and Adler’s appointment modestly alter board composition.